Published in J Virol on May 12, 2010
New paradigms for HIV/AIDS vaccine development. Annu Rev Med (2011) 2.21
Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J Virol (2011) 1.20
Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog (2011) 1.16
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest (2010) 1.04
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. J Immunother (2012) 0.92
M94 is essential for the secondary envelopment of murine cytomegalovirus. J Virol (2011) 0.90
An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Clin Dev Immunol (2013) 0.86
Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. J Clin Invest (2014) 0.86
Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo. PLoS Pathog (2012) 0.84
Dissecting the requirements for maintenance of the CMV-specific memory T-cell pool. Viral Immunol (2011) 0.82
MCMV avoidance of recognition and control by NK cells. Semin Immunopathol (2014) 0.80
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector. Immunotherapy (2016) 0.76
A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection. J Virol (2016) 0.76
Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus. PLoS Pathog (2016) 0.75
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog (2016) 0.75
Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo. J Virol (2013) 0.75
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination. Curr Opin Immunol (2017) 0.75
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med (2005) 5.46
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (1997) 5.37
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol (1992) 5.18
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med (1992) 5.11
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med (2001) 3.90
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol (1987) 3.39
Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity (2008) 3.33
Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA (2003) 3.22
Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis (2001) 3.06
Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med (1989) 2.89
Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol (2001) 2.77
Antigen-presentation properties of plasmacytoid dendritic cells. Immunity (2008) 2.57
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol (2002) 2.45
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity (2002) 2.42
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis (2004) 2.17
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med (1994) 2.17
Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol (1993) 2.04
Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med (1998) 2.04
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis (1995) 1.92
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis (1989) 1.89
Tolerance of NK cells encountering their viral ligand during development. J Exp Med (2008) 1.82
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med (2000) 1.53
Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med (1986) 1.49
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol (1996) 1.44
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol (2009) 1.40
The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol (2006) 1.34
Cytomegalovirus reinfection in young children. J Pediatr (1996) 1.34
Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med (2003) 1.34
Replication-defective viruses as vaccines and vaccine vectors. Virology (2006) 1.34
Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis (2003) 1.28
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J Virol (1992) 1.26
Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol (1996) 1.17
IFN-alphabeta-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection. J Immunol (2007) 1.13
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis (2008) 1.10
Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Virology (2001) 1.09
Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol (2009) 1.08
Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS One (2010) 1.08
Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One (2009) 1.08
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol (2002) 1.04
Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis (1997) 1.03
Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch Virol (2000) 1.01
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol (2007) 0.98
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. J Infect Dis (2009) 0.97
Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin Biol Ther (2001) 0.96
Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med (2008) 0.95
Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology (2009) 0.95
Application of molecular genetics to the design of live herpes simplex virus vaccines. Dev Biol Stand (1982) 0.95
Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo. J Virol (2003) 0.94
A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells. Virology (2006) 0.94
T-cell therapy of cytomegalovirus and human immunodeficiency virus infection. J Antimicrob Chemother (2000) 0.93
Characterisation of transcripts from the human cytomegalovirus genes TRL7, UL20a, UL36, UL65, UL94, US3 and US34. Virus Genes (2002) 0.89
The source of murine cytomegalovirus in mice receiving kidney allografts. J Infect Dis (1985) 0.86
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity. Vaccine (2003) 0.85
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J Gen Virol (2005) 0.84
The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins. J Virol (2009) 0.83
Replication-defective mutants of mouse cytomegalovirus protect against wild-type virus challenge. J Med Virol (2000) 0.81
A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection. Exp Mol Pathol (2007) 0.81
Humoral immune response to human cytomegalovirus proteins: a brief review. Comp Immunol Microbiol Infect Dis (1991) 0.79
Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature (2007) 5.82
The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity (2012) 3.65
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med (2009) 3.38
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Basophil effector function and homeostasis during helminth infection. Blood (2008) 2.56
Dynamic transcriptome analysis measures rates of mRNA synthesis and decay in yeast. Mol Syst Biol (2011) 2.37
Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity (2010) 2.35
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res (2009) 2.26
The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J Biol Chem (2003) 2.18
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol (2003) 2.11
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 2.03
Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol (2002) 1.98
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol (2007) 1.90
Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A (2006) 1.89
Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol (2010) 1.89
Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol (2006) 1.83
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A (2009) 1.77
The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo. Eur J Immunol (2010) 1.72
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog (2009) 1.67
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity (2013) 1.67
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA (2010) 1.66
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog (2008) 1.58
The phosphoproteome of toll-like receptor-activated macrophages. Mol Syst Biol (2010) 1.55
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med (2007) 1.46
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 1.45
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood (2010) 1.42
UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J Virol (2008) 1.42
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
Basophils: important emerging players in allergic and anti-parasite responses. Bioessays (2011) 1.40
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest (2015) 1.30
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity (2013) 1.28
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
Ultrashort and progressive 4sU-tagging reveals key characteristics of RNA processing at nucleotide resolution. Genome Res (2012) 1.24
AP-1A and AP-3A lysosomal sorting functions. Traffic (2002) 1.22
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J Immunol (2009) 1.20
Constitutive expression of CCR7 directs effector CD8 T cells into the splenic white pulp and impairs functional activity. J Immunol (2004) 1.18
Metabolic tagging and purification of nascent RNA: implications for transcriptomics. Mol Biosyst (2009) 1.16
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A (2013) 1.16
Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int J Cancer (2009) 1.10
Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. J Immunol (2011) 1.08
Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity. J Immunol (2007) 1.07
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol J (2009) 1.07
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog (2012) 1.06
Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history. Eur J Immunol (2004) 1.05
The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology (2005) 1.05
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest (2010) 1.04
Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J Innate Immun (2009) 1.03
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog (2010) 1.03
Conditional cytomegalovirus replication in vitro and in vivo. J Virol (2005) 1.03
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01
Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J Biol Chem (2003) 1.00
Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol (2007) 0.98
Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection. PLoS Pathog (2012) 0.98
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol (2007) 0.98
Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci Rep (2013) 0.98
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol (2010) 0.97
Th2 cells: orchestrating barrier immunity. Adv Immunol (2004) 0.97
Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology (2009) 0.95
Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol (2009) 0.95
The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens. J Immunol (2013) 0.94
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther (2006) 0.94
Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D. J Virol (2006) 0.93